Dossier
norovirus vaccine
Coverage of norovirus vaccine in the Nexus archive.
- Moderna beat earnings expectations but its norovirus vaccine trial hit a wall
Moderna exceeded Wall Street's loss estimates, but its norovirus vaccine trial failed to meet a key objective, leading to a decline in its stock price.